Advertisements




Ultragenyx Pharmaceutical Inc. (RARE) CEO Emil Kakkis on Q3 2019 Results - Earnings Call Transcript

Ultragenyx Pharmaceutical Inc. (RARE) CEO Emil Kakkis on Q3 2019 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaNov 5th, 2019

Ultragenyx Pharmaceutical Inc. (RARE) CEO Emil Kakkis on Q2 2019 Results - Earnings Call Transcript

Ultragenyx Pharmaceutical Inc. (RARE) CEO Emil Kakkis on Q2 2019 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaAug 2nd, 2019

Ultragenyx Pharmaceutical Inc."s (RARE) CEO Emil Kakkis on Q1 2019 Results - Earnings Call Transcript

Ultragenyx Pharmaceutical Inc."s (RARE) CEO Emil Kakkis on Q1 2019 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaMay 7th, 2019

Ultragenyx Pharmaceutical"s (RARE) CEO Emil Kakkis on Q1 2018 Results - Earnings Call Transcript

Ultragenyx Pharmaceutical"s (RARE) CEO Emil Kakkis on Q1 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaMay 7th, 2018

Ultragenyx Pharmaceutical"s (RARE) CEO Emil Kakkis on Q4 2018 Results - Earnings Call Transcript

Ultragenyx Pharmaceutical"s (RARE) CEO Emil Kakkis on Q4 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaFeb 20th, 2019

Ultragenyx stock halted on late-stage trial failure

Ultragenyx Pharmaceutical Inc. [s:RARE] shares were halted in Friday premarket trade on .....»»

Category: topSource: marketwatchOct 26th, 2018

Ultragenyx stock drops 14% on late-stage trial failure

Ultragenyx Pharmaceutical Inc. [s:RARE] shares dropped 14% in Friday premarket trade on .....»»

Category: topSource: marketwatchOct 26th, 2018

Mid-Day Market Update: Crude Oil Down Over 1%; Ultragenyx Pharmaceutical Shares Jump

Midway through trading Friday, the Dow traded up 0.02% to 28962.81 while the NASDAQ rose 0.25% to 9,226.30. The S&P also rose, gaining 0.16% to 3,279.97. 0 read more.....»»

Category: blogSource: benzingaJan 10th, 2020

Do Hedge Funds Love Ultragenyx Pharmaceutical Inc (RARE)?

We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Amo.....»»

Category: topSource: insidermonkeyDec 10th, 2019

Australia"s Westpac to refund people who bought new shares before money laundering bombshell

Australia's Westpac Banking Corp offered to refund investors who bought new shares weeks before a bombshell lawsuit accusing it of millions of breaches of money laundering laws, a rare step to fend off criticism about its transparency......»»

Category: topSource: reutersNov 28th, 2019

Australia"s Westpac to refund people who bought shares before money laundering bombshell

Australia's Westpac Banking Corp offered to refund investors who bought new shares weeks before a bombshell lawsuit accusing it of millions of breaches of money laundering laws, a rare step to fend off criticism about its transparency......»»

Category: topSource: reutersNov 27th, 2019

First Week of January 2020 Options Trading For Ultragenyx Pharmaceutical (RARE)

Stock Options Channel.....»»

Category: topSource: redinewsNov 19th, 2019

Ultragenyx Pharmaceutical (RARE) Investor Presentation - Slideshow

Ultragenyx Pharmaceutical (RARE) Investor Presentation - Slideshow.....»»

Category: topSource: seekingalphaNov 13th, 2019

Teva shares rise as company offers reassurance on former flagship drug Copaxone

Teva Pharmaceutical Industries Ltd.’s third-quarter results underscore the realities of its two-year-old restructuring plan under president and CEO Kåre Schultz......»»

Category: topSource: marketwatchNov 7th, 2019

Were Hedge Funds Right About Dumping Ultragenyx Pharmaceutical Inc (RARE)?

“Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn’t by muc.....»»

Category: topSource: insidermonkeyOct 26th, 2019

Ultragenyx Pharmaceutical And Ultra-Rare Diseases: A Voice For The Clinically Underserved

Ultragenyx Pharmaceutical And Ultra-Rare Diseases: A Voice For The Clinically Underserved.....»»

Category: topSource: seekingalphaSep 23rd, 2019

Kimbell Royalty Partners Lp (KRP) President and CFO Robert Davis Ravnaas Bought $51,310 of Shares

Related Stocks: KRP,.....»»

Category: blogSource: gurufocusSep 12th, 2019

Avid Bioservices Inc (CDMO) Interim President & CEO Richard B Hancock Bought $50,900 of Shares

Related Stocks: CDMO,.....»»

Category: blogSource: gurufocusSep 12th, 2019

Cars.com Inc (CARS) CEO and President Thomas Alex Vetter Bought $105,380 of Shares

Related Stocks: CARS,.....»»

Category: blogSource: gurufocusSep 12th, 2019

Aldeyra Therapeutics Inc (ALDX) President and CEO Todd C Brady Bought $102,800 of Shares

Related Stocks: ALDX,.....»»

Category: blogSource: gurufocusSep 12th, 2019